The key reasons why Johnson & Johnson (JNJ) is -12.34% away from 52-week high?

As on Wednesday, Johnson & Johnson (NYSE: JNJ) started slowly as it slid -2.20% to $154.26, before settling in for the price of $157.73 at the close. Taking a more long-term approach, JNJ posted a 52-week range of $144.95-$175.97.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 1.31%. Meanwhile, its Annual Earning per share during the time was -0.27%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 7.43%. This publicly-traded company’s shares outstanding now amounts to $2.41 billion, simultaneously with a float of $2.40 billion. The organization now has a market capitalization sitting at $371.58 billion. At the time of writing, stock’s 50-day Moving Average stood at $158.43, while the 200-day Moving Average is $159.39.

Johnson & Johnson (JNJ) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Drug Manufacturers – General industry. Johnson & Johnson’s current insider ownership accounts for 0.16%, in contrast to 72.19% institutional ownership. According to the most recent insider trade that took place on Mar 13 ’24, this organization’s EVP, Global Corp Affairs sold 8,891 shares at the rate of 162.16, making the entire transaction reach 1,441,765 in total value, affecting insider ownership by 15,043. Preceding that transaction, on Feb 16 ’24, Company’s 10% Owner sold 3,725 for 25.81, making the whole transaction’s value amount to 96,142. This particular insider is now the holder of 4,099,575 in total.

Johnson & Johnson (JNJ) Earnings and Revenue Records

If we go through the results of last quarter, which was made public on 12/30/2023, the company posted $2.29 earnings per share (EPS) for the quarter, besting the agreed prediction (set at $2.28) by $0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.72 per share during the current fiscal year.

Johnson & Johnson’s EPS increase for this current 12-month fiscal period is 7.43% and is forecasted to reach 10.99 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 4.70% through the next 5 years, which can be compared against the -0.27% growth it accomplished over the previous five years trading on the market.

Johnson & Johnson (NYSE: JNJ) Trading Performance Indicators

Let’s observe the current performance indicators for Johnson & Johnson (JNJ). It’s Quick Ratio in the last reported quarter now stands at 0.91. The Stock has managed to achieve an average true range (ATR) of 1.99. Alongside those numbers, its PE Ratio stands at $27.66, and its Beta score is 0.53. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.99. Similarly, its price to free cash flow for trailing twelve months is now 20.36.

In the same vein, JNJ’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 5.58, a figure that is expected to reach 2.64 in the next quarter, and analysts are predicting that it will be 10.99 at the market close of one year from today.

Technical Analysis of Johnson & Johnson (JNJ)

Through scrutinizing the latest numbers posted by the [Johnson & Johnson, JNJ], it can be observed that its last 5-days Average volume of 6.64 million was lower the volume of 7.12 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 45.65% While, its Average True Range was 2.00.

Raw Stochastic average of Johnson & Johnson (JNJ) in the period of the previous 100 days is set at 48.05%, which indicates a major rise in contrast to 0.14% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 12.37% that was lower than 12.93% volatility it exhibited in the past 100-days period.